{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:18:55Z","timestamp":1788347935144,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd013495","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000}}],"reference-count":299,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013495.pub2","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T17:46:14Z","timestamp":1619113574000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults"],"prefix":"10.1002","volume":"2026","author":[{"given":"Ellen","family":"Van Leeuwen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences; Ghent University; Ghent Belgium"},{"name":"Department of Public Health and Primary Care; Ghent University; Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke L","family":"van Driel","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care; Ghent University; Ghent Belgium"},{"name":"Primary Care Clinical Unit, Faculty of Medicine; The University of Queensland; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Division of Psychiatry; University College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Kendrick","sequence":"additional","affiliation":[{"name":"Primary Care, Population Sciences and Medical Education, Faculty of Medicine, Aldermoor Health Centre; University of Southampton; Southampton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Donald","sequence":"additional","affiliation":[{"name":"Primary Care Clinical Unit, Faculty of Medicine; The University of Queensland; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An IM","family":"De Sutter","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care; Ghent University; Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Robertson","sequence":"additional","affiliation":[{"name":"Cochrane Common Mental Disorders; University of York; York UK"},{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Christiaens","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences; Ghent University; Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1176\/ajp.139.3.325","article-title":"Recurrence of depression after discontinuation of long-term amitriptyline treatment","volume":"139","author":"Bialos","year":"1982","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0002|cit2","first-page":"16","article-title":"Long-term amitriptyline in chronic depression","volume":"7","author":"Bialos","year":"1985","journal-title":"Hillside Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2215-0366(18)30100-7","article-title":"Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial","volume":"5","author":"Bockting","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1192\/bjo.2018.81","article-title":"Cost-effectiveness, cost-utility and the budget impact of antidepressants versus preventive cognitive therapy with or without tapering of antidepressants","volume":"5","author":"Klein","year":"2019","journal-title":"British Journal of Psychiatry Open"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/da.22598","article-title":"Beliefs about the causes of depression and recovery and their impact on adherence, dosage, and successful tapering of antidepressants","volume":"34","author":"Klein","year":"2017","journal-title":"Depression and Anxiety"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0327(86)90031-5","article-title":"Unipolar depression in the elderly. Reoccurrence on discontinuation of tricyclic antidepressants","volume":"10","author":"Cook","year":"1986","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jamapsychiatry.2019.3900","article-title":"Prevention of recurrence after recovery from a major depressive episode with antidepressant medication lone or in combination with cognitive behavioral therapy: a phase 2 randomized clinical trial","volume":"77","author":"DeRubeis","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD013495.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jamapsychiatry.2014.1054","article-title":"Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomised clinical trial","volume":"71","author":"Hollon","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archpsyc.62.4.417","article-title":"Prevention of relapse following cognitive therapy vs medications in moderate to severe depression","volume":"62","author":"Hollon","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0010|cit10","unstructured":"Prevention of Recurrence in Depression With Drugs and CT https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00057577"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"578\u201384","DOI":"10.1093\/fampra\/cmu043","article-title":"Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care","volume":"31","author":"Eveleigh","year":"2014","journal-title":"Family Practice"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0012|cit12","first-page":"bjgpopen17X1012","article-title":"Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care","volume":"1","author":"Eveleigh","year":"2018","journal-title":"British Journal of General Practice Open"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2296-14-6","article-title":"Prescribing ANtiDepressants Appropriately (PANDA): a cluster randomized controlled trial in primary care","volume":"14","author":"Muskens","year":"2013","journal-title":"BMC Family Practice"},{"issue":"8","key":"10.1002\/14651858.CD013495.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0006-3223(02)01971-6","article-title":"Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression","volume":"54","author":"Gelenberg","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"20","key":"10.1002\/14651858.CD013495.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM200005183422001","article-title":"A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression","volume":"342","author":"Keller","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.64719\/pb.4164","article-title":"Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination","volume":"37","author":"Kocsis","year":"2003","journal-title":"Psychopharmacology Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004714-200108000-00009","article-title":"Fluoxetine in the prevention of depressive recurrences: a double-blind study","volume":"21","author":"Gilaberte","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.bp.115.168971","article-title":"Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial","volume":"208","author":"Huijbers","year":"2016","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0019|cit19","doi-asserted-by":"crossref","unstructured":"Huijbers MJ Data supplement to Huijbers et al. Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial British Journal of Psychiatry 2016 doi: 10.1192\/bjp.bp.115.168971","DOI":"10.1192\/bjp.bp.115.168971"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archpsyc.1982.04290090053011","article-title":"Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness","volume":"39","author":"Kane","year":"1982","journal-title":"Archives of General Psychiatry"},{"issue":"19","key":"10.1002\/14651858.CD013495.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.280.19.1665","article-title":"Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial","volume":"280","author":"Keller","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archpsyc.59.8.723","article-title":"Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo","volume":"59","author":"Kocsis","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD013495.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4088\/JCP.v68n0812","article-title":"The prevention of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: outcomes from the 2-year and combined maintenance phases","volume":"68","author":"Keller","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Kornstein SG Kocsis JH Ahmed S Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg\/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study International Clinical Psychopharmacology 2008 23 6 357 63","DOI":"10.1097\/YIC.0b013e328314e2cb"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0025|cit25","doi-asserted-by":"crossref","unstructured":"Kornstein SG Pedersen RD Holland PJ Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study Journal of Clinical Psychiatry 2014 75 1 62 8","DOI":"10.4088\/JCP.12m07841"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Watanabe K Thase M Kikuchi T Tsuboi T Asami Y Pappadopulos E Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg\/day versus placebo in the PREVENT study International Clinical Psychopharmacology 2017 32 5 271 80","DOI":"10.1097\/YIC.0000000000000183"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/JCP.0000000000000100","article-title":"Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg\/d","volume":"34","author":"Khan","year":"2014","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0028|cit28","unstructured":"Khan A Study comparing discontinuation symptoms of DVS SR in subjects with major depressive disorder (MDD) ClinicalTrials.gov"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0029|cit29","first-page":"10.4088","article-title":"Incidence and timing of taper\/post therapy-emergent adverse events following discontinuation of desvenlafaxine 50 mg in patients with major depressive disorder","volume":"17","author":"Ninan","year":"2015","journal-title":"Primary Care Companion CNS Disorders"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1192\/bjp.181.1.29","article-title":"Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy","volume":"181","author":"Klysner","year":"2002","journal-title":"British Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archpsyc.1996.01830090013002","article-title":"Maintenance therapy for chronic depression: a controlled clinical trial of desipramine","volume":"53","author":"Kocsis","year":"1996","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0032|cit32","first-page":"213","article-title":"Stability of remission during tricyclic antidepressant continuation therapy for dysthymia","volume":"31","author":"Kocsis","year":"1995","journal-title":"Psychopharmacology Bulletin"},{"issue":"2-3","key":"10.1002\/14651858.CD013495.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-0327(00)00256-1","article-title":"Maintenance desipramine for dysthymia: a placebo-controlled study","volume":"64","author":"Miller","year":"2001","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0034|cit34","doi-asserted-by":"crossref","unstructured":"Dunlop BW Li T Kornstein SG Correlation between patient and clinician assessments of depression severity in the PREVENT study Psychiatry Research 2013 177 177 83","DOI":"10.1016\/j.psychres.2010.02.008"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Gelenberg AJ Dunner DL Rothschild AJ Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study Journal of Nervous and Mental Diseases 2013 201 4 266 73","DOI":"10.1097\/NMD.0b013e318288d298"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.4088\/JCP.v68n0706","article-title":"Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT study","volume":"68","author":"Kocsis","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4088\/JCP.12m07841","article-title":"Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study","volume":"75","author":"Kornstein","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0038|cit38","first-page":"80","article-title":"Beyond remission. Prevention of recurrences in long-term treatment of depression. First data from the PREVENT study","volume":"14","author":"Scapicchio","year":"2008","journal-title":"Giornale Italiano di Psicopatologia \/ Italian Journal of Psychopathology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpsychires.2010.07.009","article-title":"Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study","volume":"45","author":"Thase","year":"2011","journal-title":"Journal of Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jad.2010.04.011","article-title":"Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release","volume":"126","author":"Trivedi","year":"2010","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4088\/JCP.v67n1115","article-title":"Escitalopram maintenance treatment for prevention of recurrent depression: a randomised, placebo-controlled trial","volume":"67","author":"Kornstein","year":"2006","journal-title":"Journal of Clincial Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD013495.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archpsyc.1990.01810240013002","article-title":"Three-year outcomes for maintenance therapies in recurrent depression","volume":"47","author":"Frank","year":"1990","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/archpsyc.1992.01820100013002","article-title":"Five-year outcomes for maintenance therapies in recurrent depression","volume":"49","author":"Kupfer","year":"1992","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1037\/a0013786","article-title":"Mindfulness-based cognitive therapy to prevent relapse in recurrent depression","volume":"76","author":"Kuyken","year":"2008","journal-title":"Journal of Consulting & Clinical Psychology"},{"issue":"9988","key":"10.1002\/14651858.CD013495.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(14)62222-4","article-title":"Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial","volume":"386","author":"Kuyken","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"848\u201354","DOI":"10.1016\/S0006-3223(97)00376-4","article-title":"Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia","volume":"43","author":"Mavissakalian","year":"1998","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10401230109148949","article-title":"2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia","volume":"13","author":"Mavissakalian","year":"2001","journal-title":"Annals of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archpsyc.56.9.821","article-title":"Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia","volume":"56","author":"Mavissakalian","year":"1999","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"848\u201354","DOI":"10.1016\/S0006-3223(97)00376-4","article-title":"Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia","volume":"43","author":"Mavissakalian","year":"1998","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10401230109148949","article-title":"2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia","volume":"13","author":"Mavissakalian","year":"2001","journal-title":"Annals of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archpsyc.56.9.821","article-title":"Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia","volume":"56","author":"Mavissakalian","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1192\/S0007125000297328","article-title":"The prophylactic efficacy of fluoxetine in unipolar depression","volume":"153","author":"Montgomery","year":"1988","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4088\/JCP.v65n0307","article-title":"Venlafaxine versus placebo in the preventive treatment of recurrent major depression","volume":"65","author":"Montgomery","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1742-1241.2010.02374.x","article-title":"Duloxetine 60 mg\/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study","volume":"64","author":"Kelin","year":"2010","journal-title":"International Journal of Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1743-6109.2010.02113.x","article-title":"Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder","volume":"8","author":"Montejo","year":"2011","journal-title":"Journal of Sexual Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4088\/JCP.08m04756","article-title":"Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial","volume":"70","author":"Perahia","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10608-007-9166-6","article-title":"The role of cognitive-behavioral therapy and fluoxetine in prevention of recurrence of major depressive disorder","volume":"34","author":"Petersen","year":"2010","journal-title":"Cognitive Therapy and Research"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0447.2001.00263.x","article-title":"Sertraline treatment of panic disorder: results of a long-term study","volume":"104","author":"Rapaport","year":"2001","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD013495.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/archgenpsychiatry.2010.170","article-title":"Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release","volume":"67","author":"Rickels","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-0327(99)00109-3","article-title":"Prevention of recurrent depressive episodes with milnacipran: consequences on quality of life","volume":"58","author":"Rouillon","year":"2000","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004850-200015030-00002","article-title":"Milnacipran efficacy in the prevention of recurrent depression: a 12-month placebo-controlled study","volume":"15","author":"Rouillon","year":"2000","journal-title":"International Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD013495.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archgenpsychiatry.2010.168","article-title":"Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression","volume":"67","author":"Segal","year":"2010","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1176\/ajp.154.1.31","article-title":"Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission","volume":"154","author":"Stewart","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0064|cit64","unstructured":"Medication Treatment for Depression in Nursing Home Residents https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00076622"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0065|cit65","first-page":"S147","article-title":"Antidepressant discontinuation associated with cognitive decline in older adult residents of long-term care facilities","volume":"1)","author":"Streim","year":"2012","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004850-199803000-00001","article-title":"Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study","volume":"13","author":"Terra","year":"1998","journal-title":"International Clincial Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1192\/bjp.182.6.492","article-title":"Older community residents with depression: long-term treatment with sertraline","volume":"182","author":"Wilson","year":"2003","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archpsyc.57.3.285","article-title":"Executive dysfunction and long-term outcomes of geriatric depression","volume":"57","author":"Alexopoulos","year":"2000","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S1461145705005973","article-title":"Prevention of relapse in generalized anxiety disorder by escitalopram treatment","volume":"9","author":"Allgulander","year":"2006","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1192\/bjp.bp.105.012799","article-title":"Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study","volume":"189","author":"Baldwin","year":"2006","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/YIC.0b013e3283530ad7","article-title":"Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder","volume":"27","author":"Baldwin","year":"2012","journal-title":"International Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1037\/0022-006X.73.4.647","article-title":"Preventing relapse\/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial","volume":"73","author":"Bockting","year":"2005","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000092893","article-title":"Differential predictors of response to preventive cognitive therapy in recurrent depression: a 2-year prospective study","volume":"75","author":"Bockting","year":"2006","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000110056","article-title":"Continuation and maintenance use of antidepressants in recurrent depression","volume":"77","author":"Bockting","year":"2008","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"12","key":"10.1002\/14651858.CD013495.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.4088\/JCP.08m04784blu","article-title":"Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study","volume":"70","author":"Bockting","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD013495.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1177\/0269881112441866","article-title":"A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder","volume":"26","author":"Boulenger","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0077|cit77","unstructured":"Caillard VF Boyer P Hotton JM Lepine JP Troy S Bisserbe JC Prophylactic treatment of recurrent depression: a randomized controlled trial of sertraline in remitted patients 156th Annual Meeting of the American Psychiatric Association San Francisco, CA NR426"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.295.5.499","article-title":"Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment","volume":"5","author":"Cohen","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1192\/bjp.133.1.28","article-title":"Continuation therapy with amitriptyline in depression","volume":"133","author":"Coppen","year":"1978","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0149-2918(02)85141-4","article-title":"Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks","volume":"24","author":"Croft","year":"2002","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0022-3956(93)90023-U","article-title":"Maintenance drug therapy of panic disorder","volume":"27 Suppl 1","author":"Curtis","year":"1993","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1176\/appi.ajp.158.12.1974","article-title":"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study","volume":"158","author":"Davidson","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.jcp.0000155817.21467.6c","article-title":"Maintenance therapy with fluoxetine in post traumatic stress disorder: a placebo-controlled discontinuation study","volume":"25","author":"Davidson","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4088\/JCP.v66n1115","article-title":"Safety and efficacy of escitalopram in the long-term treatment of generalised anxiety disorder","volume":"66","author":"Davidson","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.euroneuro.2008.05.002","article-title":"Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial","volume":"18","author":"Davidson","year":"2008","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0086|cit86","first-page":"48-52","article-title":"Efficacy and safety of weekly treatment with enteric-coated fluoxetine in patients with major depressive disorder","volume":"62 Suppl 22","author":"Dinan","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1037\/0022-006X.76.3.468","article-title":"Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression","volume":"76","author":"Dobson","year":"2008","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1192\/bjp.160.2.217","article-title":"Sertraline in the prevention of depression","volume":"160","author":"Doogan","year":"1992","journal-title":"British Journal of Psychiatry"},{"issue":"6 Suppl 2","key":"10.1002\/14651858.CD013495.pub2-BIB0089|cit89","first-page":"28S-33S","article-title":"Long-term treatment of major depressive disorder with paroxetine","volume":"13","author":"Duboff E","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/da.22872","article-title":"Relapse prevention with levomilnacipran ER in adults with major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study","volume":"36","author":"Durgam","year":"2019","journal-title":"Depression & Anxiety"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1176\/ajp.151.9.1295","article-title":"Cognitive behavioral treatment of residual symptoms in primary major depressive disorder","volume":"151","author":"Fava","year":"1994","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/archpsyc.55.9.816","article-title":"Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings","volume":"55","author":"Fava","year":"1998","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000063644","article-title":"Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment","volume":"71","author":"Fava","year":"2002","journal-title":"Psychotherapy & Psychosomatics"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4088\/JCP.v68n0108","article-title":"Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release","volume":"68","author":"Ferguson","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archpsyc.1989.01810090025004","article-title":"A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients","volume":"46","author":"Georgotas","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0096|cit96","unstructured":"A Double-Blind, Placebo-Controlled Continuation of Study 29060\/120 to Assess the Long Term Safety and Efficacy of Paroxetine in the Treatment of Panic Disorder and Its Role in the Prevention of Relapse\/Recurrence GSK - clinical study register; www.gsk-clinicalstudyregister.com. 1994"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0097|cit97","unstructured":"A Multicenter Placebo-Controlled Study of WELLBUTRIN (Bupropion Hydrochloride) Sustained Release (SR) for the Prevention of Relapse\/Recurrence in Subjects Whose Depression Responded to Treatment With WELLBUTRIN SR GSK - clinical study register; www.gsk-clinicalstudyregister.com. 1999"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0033291700003068","article-title":"Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial","volume":"14","author":"Glen","year":"1984","journal-title":"Psychological Medicine"},{"issue":"8","key":"10.1002\/14651858.CD013495.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.brat.2010.04.006","article-title":"The effects of mindfulness-based cognitive therapy on recurrence of depressive episodes, mental health and quality of life: a randomized controlled study","volume":"48","author":"Godfrin","year":"2010","journal-title":"Behaviour Research and Therapy"},{"issue":"8","key":"10.1002\/14651858.CD013495.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.08m04548","article-title":"Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial","volume":"70","author":"Goodwin","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/YIC.0b013e32835b0814","article-title":"Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine","volume":"28","author":"Goodwin","year":"2013","journal-title":"International Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD013495.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.JGP.0000240823.94522.4c","article-title":"Escitalopram prevents relapse in older patients with major depressive disorder","volume":"15","author":"Gorwood","year":"2007","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD013495.pub2-BIB0103|cit103","first-page":"346","article-title":"Phenelzine for chronic depression: a study of continuation treatment","volume":"47","author":"Harrison","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1192\/bjp.178.4.304","article-title":"Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy","volume":"178","author":"Hochstrasser","year":"2001","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.yic.0000171518.25963.63","article-title":"A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan","volume":"20","author":"Kamijima","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.yic.0000182118.57510.d1","article-title":"A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan","volume":"21","author":"Kamijima","year":"2006","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1176\/ajp.131.2.186","article-title":"Treatment of depression by drugs and psychotherapy","volume":"131","author":"Klerman","year":"1974","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1176\/appi.ajp.161.5.836","article-title":"A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder","volume":"161","author":"Lepine","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD013495.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jad.2012.12.009","article-title":"Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The Fifth Trial of the Danish University Antidepressant Group (DUAG-5)","volume":"148","author":"Licht","year":"2013","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"89-98","DOI":"10.1002\/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.0.CO;2-5","article-title":"Cognitive-behavioral group therapy versus phenelzine in social phobia: long term outcome","volume":"10","author":"Liebowitz","year":"1999","journal-title":"Depression and Anxiety"},{"issue":"10","key":"10.1002\/14651858.CD013495.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/da.20740","article-title":"Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial","volume":"27","author":"Liebowitz","year":"2010","journal-title":"Depression and Anxiety"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0112|cit112","doi-asserted-by":"crossref","unstructured":"Lustman PJ Clouse RE Nix BD Freedland KE Rubin EH McGill JB Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial Archives of General Psychiatry 2006 63 5 521 9","DOI":"10.1001\/archpsyc.63.5.521"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2318-11-2","article-title":"Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram?","volume":"11","author":"Lyketsos","year":"2011","journal-title":"BMC Geriatrics"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004850-200015060-00003","article-title":"An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram","volume":"15","author":"Markowitz","year":"2000","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0115|cit115","doi-asserted-by":"crossref","unstructured":"McGrath PJ Stewart JW Quitkin FM Chen Y Alpert JE Nierenberg A Predictors of relapse in a prospective study of fluoxetine treatment of major depression American Journal of Psychiatry 2006 163 9 1542 8","DOI":"10.1176\/ajp.2006.163.9.1542"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1192\/bjp.174.3.213","article-title":"Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine","volume":"174","author":"Michelson","year":"1999","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004850-199300830-00008","article-title":"A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression","volume":"8","author":"Montgomery","year":"1993","journal-title":"International Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00004850-199300830-00009","article-title":"Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression","volume":"8","author":"Montgomery","year":"1993","journal-title":"International Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD013495.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4088\/JCP.v66n1009","article-title":"A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder","volume":"66","author":"Montgomery","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0120|cit120","unstructured":"Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder https:\/\/clinicaltrials.gov\/show\/NCT00878748"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1192\/bjp.162.2.175","article-title":"How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation\/prophylaxis therapy with dothiepin","volume":"162","author":"Old Age Depression Interest Group","year":"1993","journal-title":"British Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.4088\/JCP.09m05086blu","article-title":"A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury","volume":"71","author":"Rapoport","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1176\/ajp.155.9.1247","article-title":"Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment","volume":"155","author":"Reimherr","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD013495.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1176\/ajp.149.12.1687","article-title":"Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report","volume":"149","author":"Reynolds CF","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.281.1.39","article-title":"Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years","volume":"281","author":"Reynolds","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0126|cit126","first-page":"31","article-title":"Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study","volume":"27","author":"Robinson","year":"1991","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-3223(98)00126-7","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial","volume":"44","author":"Rosenbaum","year":"1998","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4088\/JCP.12m07974","article-title":"Efficacy and safety of desvenlafaxine 50 mg\/d for prevention of relapse in major depressive disorder: a randomized controlled trial","volume":"74","author":"Rosenthal","year":"2013","journal-title":"Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD013495.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.285.10.1299","article-title":"Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial","volume":"285","author":"Sackeim","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0005-7967(01)00003-1","article-title":"Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder","volume":"40","author":"Schmidt","year":"2002","journal-title":"Behaviour Research & Therapy"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-244X-12-3","article-title":"The DARE study of relapse prevention in depression: design for a phase 1\/2 translational randomised controlled trial involving mindfulness-based cognitive therapy and supported self monitoring","volume":"12","author":"Shawyer","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.110.078626","article-title":"Family psychoeducation for major depression: randomised controlled trial","volume":"198","author":"Shimazu","year":"2011","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-244X-12-40","article-title":"Cost-effectiveness of family psychoeducation to prevent relapse in major depression: results from a randomized controlled trial","volume":"12","author":"Shimodera","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00004714-199606000-00005","article-title":"Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation","volume":"16","author":"Stein","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD013495.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4088\/JCP.11m07493","article-title":"Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study","volume":"73","author":"Stein","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/archpsyc.55.4.334","article-title":"Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo","volume":"55","author":"Stewart","year":"1998","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4088\/JCP.v64n0305","article-title":"Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder","volume":"64","author":"Stocchi","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1037\/0022-006X.68.4.615","article-title":"Prevention of relapse\/recurrence in major depression by mindfulness-based cognitive therapy","volume":"68","author":"Teasdale","year":"2000","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"10","key":"10.1002\/14651858.CD013495.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4088\/JCP.v62n1006","article-title":"Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients","volume":"62","author":"Thase","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/0269881107081550","article-title":"The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study","volume":"22","author":"Tint","year":"2008","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00004714-200012000-00009","article-title":"Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment","volume":"20","author":"Walker","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD013495.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1176\/ajp.133.7.757","article-title":"Follow-up of depressed women after maintenance treatment","volume":"133","author":"Weissman","year":"1976","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12875-019-0989-5","article-title":"Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial","volume":"20","author":"Wentink","year":"2019","journal-title":"BMC Family Practice"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0144|cit144","doi-asserted-by":"crossref","unstructured":"Wetherell JL Petkus AJ White KS Nguyen H Kornblith S Andreescu C Antidepressant treatment plus cognitive behavioral therapy for generalized anxiety disorder in older adults American Journal of Psychiatry 2013 170 7 782 9","DOI":"10.1176\/appi.ajp.2013.12081104"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004714-199806000-00003","article-title":"Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study","volume":"18","author":"Zajecka","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0146|cit146","unstructured":"Mangin D Dowson C Mulder R Wells E Toop L Dowell T The effectiveness of maintenanceSSRI treatment in primary care depression to prevent recurrence: multicentre double blinded placebo controlled RCT Proceedings of the 2015 North American Primary Care Research Group (NAPCRG) 43rd Annual Meeting 2015"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12888-016-0752-6","article-title":"Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial","volume":"16","author":"Molenaar","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13063-019-3390-8","article-title":"A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial","volume":"20","author":"Duffy","year":"2019","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13063-020-04338-7","article-title":"REDUCE (reviewing long-term antidepressant use by careful monitoring in everyday practice) Internet and telephone support to people coming off long-term antidepressants): protocol for a randomised controlled trial","volume":"21","author":"Kendrick","year":"2020","journal-title":"Trials"},{"issue":"7549","key":"10.1002\/14651858.CD013495.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"125\u201332","DOI":"10.1016\/j.jad.2015.01.055","article-title":"What factors influence long-term antidepressant use in primary care? Findings from the Australian diamond cohort study","volume":"176","author":"Ambresin","year":"2015","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0152|cit152","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0153|cit153","unstructured":"American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder dsm.psychiatryonline.org\/doi\/full\/10.1176\/appi.books.9780890425596.dsm04"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0154|cit154","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-V)","author":"American Psychiatric Association","year":"2013"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0155|cit155","first-page":"bjgpopen17X1010","article-title":"Effective management of depression in primary care: a review of the literature","volume":"1","author":"Arroll","year":"2017","journal-title":"British Journal of General Practice"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0156|cit156","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007954","article-title":"Antidepressants versus placebo for depression in primary care","author":"Arroll","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-199506000-00003","article-title":"Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale","volume":"10","author":"Bandelow","year":"1992","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"j3927","DOI":"10.1136\/bmj.j3927","article-title":"Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials","volume":"358","author":"Batelaan","year":"2017","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0160|cit160","unstructured":"Belgian Center for Pharmacotherapeutical Information (BCFI\/CBIP) Belgian National Formulary www.bcfi.be\/nl\/chapters\/11?frag=7997"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0162|cit162","volume-title":"Beck Anxiety Inventory Manual","author":"Beck","year":"1993"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"e1566","DOI":"10.1136\/bmj.e1566","article-title":"Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial","volume":"344","author":"Bergh","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nature Reviews Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD013495.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.cpr.2011.09.003","article-title":"Relapse and recurrence prevention in depression: current research and future prospects","volume":"31","author":"Beshai","year":"2011","journal-title":"Clinical Psychology Review"},{"issue":"11","key":"10.1002\/14651858.CD013495.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.euroneuro.2013.05.001","article-title":"Side effects of antidepressants during long-term use in a naturalistic setting","volume":"23","author":"Bet","year":"2013","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jad.2014.12.016","article-title":"Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta-regression","volume":"174","author":"Biesheuvel-Leliefeld","year":"2015","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00023210-200216040-00006","article-title":"Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation","volume":"16","author":"Bogetto","year":"2002","journal-title":"CNS drugs"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"759\u201369","DOI":"10.1007\/s40266-012-0003-6","article-title":"The use of antidepressants in Belgian nursing homes: focus on indications and dosages in the Phebe study","volume":"29","author":"Bourgeois","year":"2012","journal-title":"Drugs & Aging"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"990\u20139","DOI":"10.1177\/0004867417721018","article-title":"Psychotropic medication use in Australia, 2007 to 2015: changes in annual incidence, prevalence and treatment exposure","volume":"51","author":"Brett","year":"2017","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0171|cit171","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jad.2014.04.078","article-title":"Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder","volume":"166","author":"Cameron","year":"2014","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0173|cit173","first-page":"540\u201360","article-title":"CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/PPA.S110632","article-title":"Long-term antidepressant use: patient perspectives of benefits and adverse effects","volume":"10","author":"Cartwright","year":"2016","journal-title":"Patient Preference and Adherence"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0175|cit175","unstructured":"Catalogue of Bias Collaboration Holman B Bero L Mintzes B Industry sponsorship bias https:\/\/catalogofbias.org\/biases\/industry-sponsorship-bias\/"},{"issue":"10128","key":"10.1002\/14651858.CD013495.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"1357\u201366","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000496733","article-title":"Discontinuing psychotropic drugs from participants in randomized controlled trials: a systematic review","volume":"88","author":"Cohen","year":"2019","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0178|cit178","first-page":"105","article-title":"Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care","volume":"5","author":"Cruickshank","year":"2008","journal-title":"Mental Health in Family Medicine"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addbeh.2018.08.027","article-title":"A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based?","volume":"97","author":"Davies","year":"2019","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0180|cit180","unstructured":"Declercq T Habraken H Van den Ameele H Callens J De Lepeleire J Cloetens H Domus Medical Flemish College of General Practitioners Depressive Disorder in Adults www.domusmedica.be\/richtlijnen\/depressie-bij-volwassenen"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0181|cit181","unstructured":"Deeks JJ Higgins JP on behalf of the Cochrane Statistical Methods Group Chapter 9. Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0182|cit182","unstructured":"Department of Health and Social Care (DHSC) Hansard: Prescriptions Drugs \u2013 Written Question \u2013 128871 www.parliament.uk\/business\/publications\/written-questions-answers-statements\/written-question\/Commons\/2018-07-11\/163180\/"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archpsyc.65.5.513","article-title":"Population-based study of first onset and chronicity in major depressive disorder","volume":"65","author":"Eaton","year":"2008","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"e007848","DOI":"10.1136\/bmjopen-2015-007848","article-title":"What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders","volume":"5","author":"Landmark","year":"2015","journal-title":"BMJ Open"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/11599450-000000000-00000","article-title":"Studies of long-term use of antidepressants: how should the data from them be interpreted?","volume":"26","author":"El-Mallakh","year":"2012","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0186|cit186","doi-asserted-by":"publisher","first-page":"bjgpopen17X1012","DOI":"10.3399\/bjgpopen17X101265","article-title":"Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care","volume":"1","author":"Eveleigh","year":"2017","journal-title":"British Journal of General Practice Open"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"204512531987234","DOI":"10.1177\/2045125319872344","article-title":"Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators","volume":"9","author":"Eveleigh","year":"2019","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD013495.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1176\/ajp.155.10.1443","article-title":"Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression","volume":"155","author":"Fava","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000370338","article-title":"Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review","volume":"84","author":"Fava","year":"2015","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000491524","article-title":"Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review","volume":"87","author":"Fava","year":"2018","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","article-title":"Conceptualization and rationale for consensus definitions of terms in major depressive disorder remission, recovery, relapse, and recurrence","volume":"48","author":"Frank","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0895-4356(98)00109-7","article-title":"Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project","volume":"51","author":"Gandek","year":"1998","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"653\u201361","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"697\u2013705","DOI":"10.3109\/00048671003705441","article-title":"Meta-analysis of relapse prevention antidepressant trials in depressive disorders","volume":"44","author":"Glue","year":"2010","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2004.09.001","article-title":"Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study","volume":"78","author":"Gorgels","year":"2005","journal-title":"Drug Alcohol Dependence"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0196|cit196","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archpsyc.1991.01810280029004","article-title":"Methodologic issues in maintenance therapy clinical trials","volume":"48","author":"Greenhouse","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0198|cit198","first-page":"789\u201394","article-title":"Tapering strips for paroxetine and venlafaxine","volume":"55","author":"Groot","year":"2013","journal-title":"Tijdschrift Psychiatrie"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/17522439.2018.1469163","article-title":"Antidepressant tapering strips to help people come off medication more safely","volume":"10","author":"Groot","year":"2018","journal-title":"Psychosis"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045125320954609","article-title":"Outcome of antidepressant drug discontinuation with tapering strips after 1\u20135 years","volume":"10","author":"Groot","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/appi.ajp.2015.15040476","article-title":"The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature","volume":"73","author":"Guidi","year":"2016","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"e66455","DOI":"10.1371\/journal.pone.0066455","article-title":"Antidepressant utilization and suicide in Europe: an ecological multi-national study","volume":"8","author":"Gusm\u00e3o","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1192\/apt.bp.105.001966","article-title":"Recognising and managing antidepressant discontinuation symptoms","volume":"13","author":"Haddad","year":"2007","journal-title":"Advances in Psychiatric Treatment"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0204|cit204","first-page":"50","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Health Psychology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/08039480600937140","article-title":"Occupational Functioning Scale (OFS) \u2013 an instrument for assessment of work ability in psychiatric disorders","volume":"60","author":"Hannula","year":"2006","journal-title":"Nordic Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","article-title":"How do antidepressants work? New perspectives for refining future treatment approaches","volume":"4","author":"Harmer","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fpsyt.2017.00275","article-title":"Methodological flaws, conflicts of interest, and scientific fallacies: implications for the evaluation of antidepressants' efficacy and harm","volume":"8","author":"Hengartner","year":"2017","journal-title":"Frontiers in Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0209|cit209","doi-asserted-by":"crossref","unstructured":"Hengartner MP Davies J Read J Antidepressant withdrawal - the tide is finally turning Epidemiology and Psychiatric Sciences 2019 29 e52 31434594","DOI":"10.1017\/S2045796019000465"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"204512532092169","DOI":"10.1177\/2045125320921694","article-title":"How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding","volume":"10","author":"Hengartner","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0212|cit212","unstructured":"Higgins JP Altman DG Chapter 8. Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"8","key":"10.1002\/14651858.CD013495.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2165\/00023210-200620080-00005","article-title":"Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome","volume":"20","author":"Himei","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2215-0366(19)30032-X","article-title":"Tapering of SSRI treatment to mitigate withdrawal symptoms","volume":"6","author":"Horowitz","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0215|cit215","first-page":"l6103","article-title":"NICE updates: antidepressant guidelines to reflect severity and length of withdrawal symptoms","volume":"367","author":"Iacobucci","year":"2019","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0216|cit216","unstructured":"REDUCE Programme WS4: REviewing long term anti-DEpressant Use by Careful monitoring in Everyday practice www.isrctn.com\/ISRCTN15036829"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12888-016-1173-2","article-title":"Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and trial sequential analysis","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD013495.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1017\/S1041610216001150","article-title":"Psychotropic drug prescriptions in Western European nursing homes","volume":"28","author":"Janus","year":"2016","journal-title":"International Psychogeriatrics \/ IPA"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.3399\/bjgp12X658304","article-title":"Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study","volume":"62","author":"Johnson","year":"2012","journal-title":"British Journal of General Practice"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12875-017-0643-z","article-title":"'Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed doses","volume":"18","author":"Johnson","year":"2017","journal-title":"BMC Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"109\u201319","DOI":"10.1016\/j.amjopharm.2011.03.001","article-title":"Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States","volume":"9","author":"Karkare","year":"2011","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0222|cit222","first-page":"1423\u201336","article-title":"Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials","volume":"69","author":"Kaymaz","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"19","key":"10.1002\/14651858.CD013495.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/psb.1389","article-title":"Long-term antidepressant treatment: time for a review?","volume":"26","author":"Kendrick","year":"2015","journal-title":"Prescriber"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cct.2006.10.012","article-title":"Clinical trials and the response rate illusion","volume":"28","author":"Kirsch","year":"2007","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fpsyt.2019.00407","article-title":"Placebo effect in the treatment of depression and anxiety","volume":"10","author":"Kirsch","year":"2019","journal-title":"Frontiers in Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD013495.pub2-BIB0226|cit226","first-page":"1180","article-title":"Average duration of treatment with antidepressants among concession card holders in Australia","volume":"50","author":"Kjosavik","year":"2016","journal-title":"Journal of Psychiatric Practice"},{"issue":"20","key":"10.1002\/14651858.CD013495.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.2017.5706","article-title":"Management of depression in older adults: a review","volume":"317","author":"Kok","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamapsychiatry.2016.0076","article-title":"Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials","volume":"73","author":"Kuyken","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0229|cit229","first-page":"MR000033","article-title":"Industry sponsorship and research outcome","volume":"2","author":"Lundh","year":"2017","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD013495.pub2-BIB0230|cit230","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013371","article-title":"Deprescribing of chronic benzodiazepine receptor agonists for insomnia in adults","author":"Ma","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0231|cit231","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012855.pub2","article-title":"Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults","author":"Machmutow","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1171","key":"10.1002\/14651858.CD013495.pub2-BIB0232|cit232","first-page":"U379","article-title":"The nature and prevalence of psychological problems in New Zealand primary healthcare: a report on Mental Health and General Practice Investigation (MaGPIe)","volume":"116","author":"MaGPIe Research Group","year":"2003","journal-title":"New Zealand Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-0327(88)90072-9","article-title":"The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders","volume":"14","author":"Maier","year":"1988","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1370\/afm.2315","article-title":"Legacy drug prescribing patterns in primary care","volume":"16","author":"Mangin","year":"2018","journal-title":"Annals of Family Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00127-016-1306-4","article-title":"Influences on antidepressant prescribing trends in the UK: 1995-2011","volume":"52","author":"Mars","year":"2017","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1017\/S0033291707000074","article-title":"The long-term course of depressive disorders in the Lundby Study","volume":"37","author":"Mattisson","year":"2007","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0237|cit237","doi-asserted-by":"crossref","unstructured":"Maund E Dewar-Haggart R Williams S Bowers H Geraghty AWA Leydon G Barriers and facilitators to discontinuing antidepressant use: a systematic review and thematic synthesis Journal of Affective Disorders 2019 245 38 62 10.1016\/j.jad.2018.10.107","DOI":"10.1016\/j.jad.2018.10.107"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1370\/afm.2336","article-title":"Managing antidepressant discontinuation: a systematic review","volume":"17","author":"Maund","year":"2019","journal-title":"Annals of Family Medicine"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"k1073","DOI":"10.1136\/bmj.k1073","article-title":"Effectiveness of antidepressants","volume":"360","author":"McCormack","year":"2018","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"57\u201361","DOI":"10.1007\/s00228-004-0726-3","article-title":"Incidence and determinants of long-term use of antidepressants","volume":"60","author":"Meijer","year":"2004","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1017\/S0033291709991036","article-title":"How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment","volume":"40","author":"Moffitt","year":"2009","journal-title":"Psychological Medicine"},{"issue":"7","key":"10.1002\/14651858.CD013495.pub2-BIB0242|cit242","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4088\/JCP.13m08443","article-title":"National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey","volume":"75","author":"Mojtabai","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0244|cit244","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003012.pub2","article-title":"Active placebos versus antidepressants for depression","author":"Moncrieff","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"382-9","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.yic.0000137184.64610.c8","article-title":"Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study","volume":"19","author":"Montgomery","year":"2004","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0247|cit247","doi-asserted-by":"publisher","first-page":"e024886","DOI":"10.1136\/bmjopen-2018-024886","article-title":"Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis","volume":"9","author":"Munkholm","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JCP.0b013e3181c8ae80","article-title":"Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome","volume":"30","author":"Murata","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0249|cit249","first-page":"252","article-title":"The NHG guideline depression (second revision of the NHG guideline depressive disorder)","volume":"55","author":"Van Weel-Baumgarten","year":"2012","journal-title":"Huisarts en Wetenschap"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0250|cit250","unstructured":"Dutch College of General Practitioners (NHG) Deprescribing SSRI and TCA www.nhg.org\/sites\/default\/files\/content\/nhg_org\/uploads\/201809_multidisciplinair_document_afbouwen_ssris_en_snris.pdf"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0251|cit251","unstructured":"National Institute for Health and Care Excellence (NICE) Depression in adults: recognition and management. [CG90] www.nice.org.uk\/guidance\/cg90"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0252|cit252","unstructured":"National Institute for Health and Care Excellence (NICE) Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care. [CG113] www.nice.org.uk\/guidance\/cg113"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1360-0443.2011.03686.x","article-title":"What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors","volume":"107","author":"Nielsen","year":"2012","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0254|cit254","unstructured":"Organisation of Economic Co-operation and Development (OECD) Antidepressant drugs consumption dx.doi.org\/10.1787\/health_glance-2017-graph181-en"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0255|cit255","doi-asserted-by":"crossref","unstructured":"Ormel J Spinhoven P de Vries YA Cramer AOJ Siegle GJ Bockting CLH The antidepressant standoff: why it continues and how to resolve it Psychological Medicine 2020 50 2 177 86 31779735","DOI":"10.1017\/S0033291719003295"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/ageing\/afl023","article-title":"Prevalence, duration and indications for prescribing of antidepressants in primary care","volume":"35","author":"Petty","year":"2006","journal-title":"Age and Ageing"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"106\u201312","DOI":"10.3109\/13814781003692463","article-title":"Guideline recommendations for long-term treatment of depression with antidepressants in primary care: a critical review","volume":"16","author":"Piek","year":"2010","journal-title":"European Journal of General Practice"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.cpr.2011.05.002","article-title":"The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis","volume":"31","author":"Piet","year":"2011","journal-title":"Clinical Psychology Review"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000318293","article-title":"Efficacy and effectiveness of antidepressants: current status of research","volume":"79","author":"Pigott","year":"2010","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"1","key":"10.1002\/14651858.CD013495.pub2-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/070674371506000104","article-title":"The STAR*D trial: it is time to reexamine the clinical beliefs that guide the treatment of major depression","volume":"60","author":"Pigott","year":"2015","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0261|cit261","first-page":"26","article-title":"The medicalisation of misery: a critical realist analysis of the concept of depression","volume":"8","author":"Pilgrim","year":"1999","journal-title":"Journal of Mental Health"},{"issue":"5","key":"10.1002\/14651858.CD013495.pub2-BIB0262|cit262","first-page":"339\u201351","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline","volume":"64","author":"Pottie","year":"2018","journal-title":"Canadian Family Physician"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0263|cit263","first-page":"1","article-title":"Antidepressant use in persons aged 12 and over: United States, 2005-2008","volume":"76","author":"Pratt","year":"2011","journal-title":"NCHS Data Brief"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0264|cit264","unstructured":"Pratt LA Brody DJ Gu Q Antidepressant use among persons aged 12 and over: United States, 2011\u20132014 www.cdc.gov\/nchs\/data\/databriefs\/db283.pdf"},{"issue":"7","key":"10.1002\/14651858.CD013495.pub2-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.pnpbp.2010.07.022","article-title":"A cognitive neuropsychological model of antidepressant drug action","volume":"35","author":"Pringle","year":"2011","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0266|cit266","unstructured":"Royal College of Psychiatrists 2019 Position statement on antidepressants and depression https:\/\/www.rcpsych.ac.uk\/docs\/default-source\/improving-care\/better-mh-policy\/position-statements\/ps04_19---antidepressants-and-depression.pdf?sfvrsn=ddea9473_5"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000496734","article-title":"Withdrawal confounding in randomized controlled trials of antipsychotic, antidepressant, and stimulant drugs, 2000-2017","volume":"88","author":"Recalt","year":"2019","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","article-title":"Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action","volume":"38","author":"Reeve","year":"2017","journal-title":"European Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0269|cit269","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0270|cit270","unstructured":"Infospot www.riziv.fgov.be\/SiteCollectionDocuments\/infospot-2014-02-nl.pdf"},{"issue":"28","key":"10.1002\/14651858.CD013495.pub2-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16280","article-title":"The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review","volume":"16","author":"Rodgers","year":"2012","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-3223(98)00126-7","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial","volume":"44","author":"Rosenbaum","year":"1988","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S2215-0366(19)30182-8","article-title":"Tapering of SSRI treatment to mitigate withdrawal symptoms","volume":"6","author":"Ruhe","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013495.pub2-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mpr.79","article-title":"The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms","volume":"9","author":"Rush","year":"2000","journal-title":"International Journal of Methods in Psychiatric Research"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000489498","article-title":"The efficacy of a group CBT relapse prevention program for remitted anxiety disorder patients who discontinue antidepressant medication: a randomized controlled trial.","volume":"87","author":"Scholten","year":"2018","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"204512532093340","DOI":"10.1177\/2045125320933404","article-title":"Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations","volume":"10","author":"Scholten","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology."},{"key":"10.1002\/14651858.CD013495.pub2-BIB0277|cit277","volume-title":"Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse","author":"Segal","year":"2002"},{"issue":"11","key":"10.1002\/14651858.CD013495.pub2-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"1001\u20136","DOI":"10.1001\/archpsyc.1997.01830230033005","article-title":"Recovery from major depression: a 10-year prospective follow-up across multiple episodes","volume":"54","author":"Solomon","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"18","key":"10.1002\/14651858.CD013495.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD013495.pub2-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"16","key":"10.1002\/14651858.CD013495.pub2-BIB0281|cit281","first-page":"1","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0282|cit282","unstructured":"UK Royal College of Psychiatrists Stopping antidepressants https:\/\/www.rcpsych.ac.uk\/docs\/default-source\/mental-health\/treatments-and-wellbeing\/print-outs\/stopping-antidepressant-printable.pdf?sfvrsn=2c9a63e0_2"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"735\u201340","DOI":"10.1007\/s00228-003-0687-y","article-title":"Controlled withdrawal of selective serotonin inhibitor drugs in elderly patients in nursing homes with no indication of depression","volume":"59","author":"Ulfvarson","year":"2003","journal-title":"European Journal Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD013495.pub2-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4088\/JCP.08m04943","article-title":"Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study","volume":"70","author":"Valuck","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013495.pub2-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00228-005-0921-x","article-title":"Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation","volume":"61","author":"Geffen","year":"2005","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0286|cit286","unstructured":"Van Leeuwen E Study results Email to: J. Streim"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0287|cit287","unstructured":"Van Leeuwen E Study results Email to: W. Kuyken"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0288|cit288","unstructured":"Van Leeuwen E Results RCT Email to: P Lucassen"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0289|cit289","unstructured":"Van Leeuwen E Study results Email to: M Huijbers"},{"issue":"3","key":"10.1002\/14651858.CD013495.pub2-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1192\/bjp.189.3.213","article-title":"Strategies for discontinuing long-term benzodiazepine use: meta-analysis","volume":"189","author":"Voshaar","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"m3200","DOI":"10.1136\/bmj.m3200","article-title":"The trouble with antidepressants: why the evidence overplays benefits and underplays risks - an essay by John B Warren","volume":"370","author":"Warren","year":"2020","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0293|cit293","unstructured":"World Health Organization (WHO) Fact Sheets Depression www.who.int\/news-room\/fact-sheets\/detail\/depression"},{"issue":"9","key":"10.1002\/14651858.CD013495.pub2-BIB0294|cit294","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006727.pub3","article-title":"Continuation and maintenance treatments for depression in older people","author":"Wilkinson","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD013495.pub2-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/0269881110379307","article-title":"British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders","volume":"24","author":"Wilson","year":"2010","journal-title":"Journal of Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD013495.pub2-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/2045125315612334","article-title":"A review of the management of antidepressant discontinuation symptoms","volume":"5","author":"Wilson","year":"2015","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"20","key":"10.1002\/14651858.CD013495.pub2-BIB0297|cit297","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1001\/jama.2016.3445","article-title":"Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006-2015","volume":"315","author":"Wong","year":"2016","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013495.pub2-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"j603","DOI":"10.1136\/bmj.j603","article-title":"Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system","volume":"356","author":"Wong","year":"2017","journal-title":"British Medical Journal"},{"issue":"12","key":"10.1002\/14651858.CD013495.pub2-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1592\/phco.29.12.1408","article-title":"Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies","volume":"29","author":"Woolley","year":"2009","journal-title":"Pharmacotherapy"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:06:12Z","timestamp":1788347172000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013495.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":299,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013495.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]}}}